Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany

Huebner, Hanna; Kurbacher, Christian M.; Kuesters, Geoffrey; Hartkopf, Andreas D.; Lux, Michael P.; Huober, Jens; Volz, Bernhard; Taran, Florin-Andrei; Overkamp, Friedrich; Tesch, Hans; Haeberle, Lothar; Lueftner, Diana; Wallwiener, Markus; Mueller, Volkmar; Beckmann, Matthias W.; Belleville, Erik; Ruebner, Matthias; Untch, Michael; Fasching, Peter A.; Janni, Wolfgang; Fehm, Tanja N.; Kolberg, Hans-Christian; Wallwiener, Diethelm; Brucker, Sara Y.; Schneeweiss, Andreas; Ettl, Johannes

Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany

Author:

Huebner, Hanna; Kurbacher, Christian M.; Kuesters, Geoffrey; Hartkopf, Andreas D.; Lux, Michael P.; Huober, Jens; Volz, Bernhard; Taran, Florin-Andrei; Overkamp, Friedrich; Tesch, Hans; Haeberle, Lothar; Lueftner, Diana; Wallwiener, Markus; Mueller, Volkmar; Beckmann, Matthias W.; Belleville, Erik; Ruebner, Matthias; Untch, Michael; Fasching, Peter A.; Janni, Wolfgang; Fehm, Tanja N.; Kolberg, Hans-Christian; Wallwiener, Diethelm; Brucker, Sara Y.; Schneeweiss, Andreas; Ettl, Johannes

Tübinger Autor(en):

Hartkopf, Andreas
Wallwiener, Diethelm
Brucker, Sara

Published in:

Bmc Cancer (2020), Bd. 20, Article 1091

Verlagsangabe:

Bmc

Language:

English

Full text:

http://dx.doi.org/10.1186/s12885-020-07546-1

ISSN:

1471-2407